Mahesan Subramaniam: China Unveils First Humanoid Pregnancy Robot
Mahesan Subramaniam, Founder and Chief Executive Officer of TRI International Group, shared a post on LinkedIn:
“China has taken a bold step into the future of biotechnology with the creation of the world’s first humanoid pregnancy robot. Led by Dr. Zhang Qifeng at Nanyang Technological University, researchers have combined robotics with an artificial womb designed to sustain a fetus for ten months and even deliver birth. This innovation could provide new possibilities for couples struggling with infertility and nations facing declining birth rates.
The artificial womb operates by replicating the natural conditions of pregnancy through a nutrient-rich amniotic fluid system that supports fetal growth. This idea builds on past breakthroughs, such as the 2017 experiment where scientists successfully nurtured a premature lamb outside its mother’s body. By refining that concept through robotics, scientists aim to simulate human pregnancy in a controlled, artificial environment, bridging the gap between medicine and machine.
Expected to cost below 100,000 yuan (about $14,000), this technology could soon become more than just theory. However, its arrival also opens serious ethical questions about parenthood, natural birth, and the limits of science. As reproductive robotics evolves, the world will need to decide how far it’s willing to go in reshaping what it means to create life.
Source: Nanyang Technological University, Reproductive Robotics Research.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 06:53New Data on Assisted Hatching in Assisted Reproduction – C.L.A.R. Consulting
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
-
Dec 13, 2025, 04:22Placenta-Targeted Nanoparticles: A New Frontier in Recurrent Pregnancy Loss – Reproduction and Fertility
